J Biol Chem (2001) 276(40):3740914.10.1074/jbc.M106728200 67 GattoFFeeldersRvan der PasRKrosJMDoganFvan KoetsveldPMet al-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly
How Muscle Loss Impacts Your Health: GLP-1 Drugs Muscle loss from GLP-1 drugs negatively impacts: Cardiovascular health Metabolic health Physical function Given the importance of muscle mass on your health and physical function, its important to find and incorporate into your lifestyle, factors that prevent muscle loss during GLP-1 medication use
Ozempic, Rybelsus, Saxenda, Victoza, Wegovy, Mounjaro, Trulicity, Zepbound and Byetta remain approved by the U.S
Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor

Subcutaneous injection (most common): Injection sites: Abdomen (2 inches from the navel, any direction) Upper thighs (front or outer) Upper arms (outer aspect, if administered by an assistant) For localized treatment: near the injury site (within 23 inches) Procedure: Clean the injection site with an alcohol swab Let the alcohol dry completely Pinch the skin to create a fold of subcutaneous tissue Insert the needle at a 45-degree angle Inject slowly over 510 seconds Withdraw the needle smoothly Apply gentle pressure if needed (do not rub) Intramuscular injection (alternative): Injection sites: Deltoid (shoulder) Vastus lateralis (outer thigh) Gluteus medius (upper outer buttock) Procedure: Clean the site thoroughly Insert the needle at a 90-degree angle Aspirate slightly to confirm you are not in a blood vessel Inject slowly and steadily Withdraw the needle and apply pressure Dosing Frequency and Timing Frequency depends on research goals and injury characteristics

Clin Transl Gastroenterol [Internet]